Jemperli fachinformation
WebAug 17, 2024 · JEMPERLI is indicated for the treatment of adult patients with mismatch repair deficient (dMMR) recurrent or advanced: endometrial cancer (EC), as determined by an FDA-approved test, that has progressed on or following prior treatment with a platinum-containing regimen, or WebApr 29, 2024 · Listen to a soundcast of the April 22 & 23 2024 FDA approvals of Jemperli (dostarlimab-gxly) for patients with mismatch repair deficient recurrent or advanced endometrial cancer and Zynlonta ...
Jemperli fachinformation
Did you know?
WebFeb 9, 2024 · For the 500-mg dose, withdraw 10 mL of JEMPERLI from a vial using a disposable sterile syringe made of polypropylene and dilute into an intravenous infusion bag containing 0.9% Sodium Chloride Injection, USP or 5% Dextrose Injection, USP to a final concentration between 2 to 10 mg/mL (maximum 250 mL). WebFeb 27, 2024 · JEMPERLI (dostarlimab-gxly) injection is a clear to slightly opalescent, colorless to yellow solution supplied in a carton containing one 500 mg/10 mL (50 …
WebMar 13, 2024 · JEMPERLI is a prescription medicine used to treat adult females with uterine cancer (endometrial cancer). JEMPERLI may be used when: the tumor has been shown by … WebFeb 1, 2024 · Jemperli is a monoclonal antibody that belongs to a class of drugs that bind to either the programmed death receptor-1 (PD-1) or PD-ligand 1 (PD-L1), blocking the PD …
WebJemperli (dostarlimab) was approved for the following therapeutic use: Jemperli is indicated as monotherapy for the treatment of adult patients with recurrent or advanced … WebJEMPERLI contains the active substance dostarlimab, which is a monoclonal antibody, a type of protein designed to recognise and attach to a specific target substance in the body. JEMPERLI works by helping your immune system fight your cancer. It is given when endometrial cancer (cancer of the lining of the womb) has spread, or cannot be taken
Jemperli is a cancer medicine for treating certain types of endometrial cancer (cancer of the womb) that are advanced or have come back and have got worse despite treatment involving a platinum-based cancer medicine. Jemperli is for endometrial cancer where the cancer cells have genetic abnormalities (called mismatch repair deficiency and high ...
WebJEMPERLI (dostarlimab for injection) January 31, 2024 6Page of 34 • Subsequent dosing beginning 3 weeks after Dose 4 (Dose 5 onwards): 1,000 mg every 6 weeks The dosage regimen is presented in Table 1. Table 1 Dosage regimen for patients treated with JEMPERLI Administer JEMPERLI as an intravenous infusion over 30 minutes. asarina pharma aktieWebJEMPERLI is a prescription medicine used to treat adults with a kind of uterine cancer called endometrial cancer and may be used when: your tumor has been shown by a laboratory test to be mismatch repair deficient (dMMR), and your cancer has returned, or it has spread or cannot be removed by surgery (advanced cancer), and you have received chemotherapy … asarina barclaina climberWebJemperli 500 mg Konzentrat zur Herstellung einer Infusionslösung 1 Durchstechflasche, PZN 16902236 DOWNLOAD Fachinformation DOWNLOAD Gebrauchsinformation 🔒 Produktinformationen Sie möchten mehr über Jemperli erfahren? Kontaktieren Sie uns Bei Fragen zu unseren Produkten nehmen Sie gerne Kontakt auf. Besuch anfordern asar imhotep youtube